KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Basic) (2016 - 2026)

Idexx Laboratories has reported EPS (Basic) over the past 17 years, most recently at $3.11 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 17.36% year-over-year to $3.11; the TTM value through Dec 2025 reached $13.18, up 22.26%, while the annual FY2025 figure was $13.17, 22.28% up from the prior year.
  • EPS (Basic) for Q4 2025 was $3.11 at Idexx Laboratories, down from $3.43 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $3.66 in Q2 2025 and troughed at $1.57 in Q2 2022.
  • A 5-year average of $2.55 and a median of $2.5 in 2023 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): soared 82.44% in 2021 and later crashed 33.76% in 2022.
  • Year by year, EPS (Basic) stood at $1.92 in 2021, then rose by 8.33% to $2.08 in 2022, then increased by 12.5% to $2.34 in 2023, then rose by 13.25% to $2.65 in 2024, then increased by 17.36% to $3.11 in 2025.
  • Business Quant data shows EPS (Basic) for IDXX at $3.11 in Q4 2025, $3.43 in Q3 2025, and $3.66 in Q2 2025.